Skip to content

Clinical trials

Phase 3 Carcinoma, Hepatocellular trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 3 Clear all

249 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20013
20024
20031
20041
20057
20065
20078
20088
20097
201011
201111
20125
201314
20148
201510
201616
201712
201814
201923
202010
20219
202216
202313
20245
20257
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed88
Unknown status70
Recruiting27
Terminated24
Active, not recruiting17
Not yet recruiting11
Withdrawn10
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University48
Guangxi Medical University13
AstraZeneca6
Bayer6
Fudan University6
Hoffmann-La Roche6
Merck Sharp & Dohme LLC6
Shanghai Zhongshan Hospital6
Bristol-Myers Squibb5
Assistance Publique - Hôpitaux de Paris4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular249
Liver Neoplasms41
Neoplasms13
Recurrence8
Fibrosis7
Carcinoma6
Bile Duct Neoplasms4
Carcinoma, Renal Cell4
Gallbladder Neoplasms4
Hepatitis C4

Trials

Showing 1 to 25 of 249. Each trial links to its page on Pharma Observatory.

149 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.